Dr Naushad Forbes
Chairman
Past President, CII Chairman,
CII National Committee on IP Co-Chairperson, Forbes Marshall
Dr Naushad Forbes
Chairman
Past President, CII Chairman CII National Committee on IP Co-Chairperson, Forbes Marshall
Mr.Vivek Shah
Vice Chairman
CII National Committee on IP(2024-25) and CEO, Meril Life Sciences
Read MoreMr.Vivek Shah
Vice Chairman
Vivek Shah is chief executive officer (CEO) of the Meril group of companies. As CEO, his responsibilities include the following:
Strategy development for all existing and new businesses,
Expanding the global on-ground presence of the group into all key markets, and
Increasing Meril’s market share.
In his 15 years at Meril, Mr Shah has led a number of critical initiatives across businesses that have made the company the most significant player in its areas. For instance:
He built the most effective sales team in orthopaedic devices, which is why Meril has the largest share of the market in India
He worked with doctors across the country (and globally) and product design teams to simplify and thus make the surgical process easier
Over the last 4 years, he has been building the endo-surgery business, and a products team that would make Meril the largest player in surgical devices in India.
Bringing over 25 years of extensive experience to the table, Mr. Shah has proven his leadership prowess in managing large teams within the healthcare industry. Notably, a significant portion of his career has been dedicated to making impactful contributions at Meril.
Mr. Shaheen Majeed
Vice Chairman
CII National Committee on IP(2024-25)
and Global CEO & Managing Director of the Sami-Sabinsa Group
Mr. Shaheen Majeed
Vice Chairman
CII National Committee on IP(2024-25) and Global CEO & Managing Director of the Sami-Sabinsa Group
Shaheen Majeed, Global CEO & Managing Director, Sami-Sabinsa Group
Shaheen has held diverse roles, including sales, supply chain management, manufacturing, regulatory compliance, and global marketing. As President Worldwide, his innovative global strategies expanded the company’s reach across multiple continents. Over 25 years, he shaped the company into a global nutraceutical ingredient leader.
Some achievements include ensuring the company’s adherence to cGMP and regulatory standards, guiding numerous clinical studies to publication, and launching products that are category leaders. Before his current position, Shaheen served as CEO of HB Natural Ingredients, BGG Americas, and Algae Health Sciences, subsidiaries of BGG World.
Shaheen Majeed is the Global CEO & Managing Director of the Sami-Sabinsa Group. Shaheen has held diverse roles, including sales, supply chain management, manufacturing, regulatory compliance, and global marketing. As President Worldwide, his innovative global strategies expanded the company’s reach across multiple continents. Over 25 years, he shaped the company into a global nutraceutical ingredient leader. Some achievements include ensuring the company’s adherence to cGMP and regulatory standards, guiding numerous clinical studies to publication, and launching products that are category leaders.
He holds 62 US & International patents and has authored 31 peer-reviewed publications, showcasing his dedication to advancing scientific research and product innovation. Before his current position, Shaheen served as CEO of HB Natural Ingredients, BGG Americas, and Algae Health Sciences, subsidiaries of BGG World.
Shaheen Majeed is the Global CEO & Managing Director of the Sami-Sabinsa Group, where he has spent over 25 years shaping the company into a global leader in the nutraceutical ingredient industry. Throughout his tenure, Shaheen has held diverse roles, including sales, supply chain management, manufacturing, regulatory compliance, and global marketing. During his four-year term as President Worldwide, his innovative global strategies expanded the company’s reach across multiple continents.
Shaheen’s achievements include ensuring the company’s adherence to cGMP and regulatory standards, guiding numerous clinical studies to publication, and launching products that are category leaders. His emphasis on education opportunities delving into the clinical studies supporting Sabinsa’s portfolio included renewing the multi-day Sabinsa on Wheels conference and launching the more streamlined Sabinsa Knowledge Day, both global educational platforms that foster direct engagement with formulators and marketers. He holds 62 US & International patents and has authored 31 peer-reviewed publications, showcasing his dedication to advancing scientific research and product innovation. His status as an industry thought leader is demonstrated by his dozens of speaking engagements and hundreds of trade publication interviews through the years.
A passionate leader, Shaheen is committed to nurturing talent across all levels of the company, actively promoting team-building and leadership development to ensure a dynamic, supportive, inclusive, and innovative workplace. His initiatives have empowered teams globally, facilitating open communication and shared success.
Before his current position, Shaheen served as CEO of HB Natural Ingredients, BGG Americas, and Algae Health Sciences, subsidiaries of BGG World. His broad experience and strategic vision continue to drive Sabinsa’s growth and innovation on the world stage.